Skip to content

Ginkgo Bioworks DNA Free cash flow yield

Free cash flow yield at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.7%+0.1pp
Charles River Laboratories logo
Charles River LaboratoriesCRL
4.6%-2.7pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-17.9%-2.6pp
TEC
Bio-TechneTECH
3.3%+0.9pp
Azenta logo
AzentaAZTA
3.8%
Regenxbio logo
RegenxbioRGNX
-54.7%-272pp

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

Based on trailing twelve months.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's free cash flow yield?
Ginkgo Bioworks (DNA) reported free cash flow yield of -44.3% in Q1 2026.
How has Ginkgo Bioworks's free cash flow yield changed year-over-year?
Ginkgo Bioworks's free cash flow yield increased by 57.6% year-over-year, from -104.4% to -44.3%.
What is the long-term trend for Ginkgo Bioworks's free cash flow yield?
Over 4 years (2021 to 2025), Ginkgo Bioworks's free cash flow yield has grown at a 99.7% compound annual growth rate (CAGR), from -2.2% to -35.5%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.